Showing results (291-300 of 306) with videos related to
Sort By:
Pageof 31
Bone Marrow Transplantation|June 1, 1997
Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell contentC H Weaver, J Potz, J Redmond, et al.Bone Marrow Transplantation|September 1, 1991
Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapyR H Van der Jagt, F R Appelbaum, F B Petersen, et al.Blood|October 15, 1995
Unrelated donor marrow transplantation in childrenA Balduzzi, T Gooley, C Anasetti, et al.Bone Marrow Transplantation|April 1, 1997
Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analysesC H Weaver, W H West, L S Schwartzberg, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancerC H Weaver, L S Schwartzberg, R Birch, et al.The New England Journal of Medicine|April 2, 1998
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemiaJ A Hansen, T A Gooley, P J Martin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 1998
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's diseaseK Schiffman, C D Buckner, R Maziarz, et al.Cancer Chemotherapy Reports|November 1, 1975
Combination chemotherapy for acute nonlymphoblastic leukemia in adultsH Glucksberg, C D Buckner, A Fefer, et al.Journal of Hematotherapy|May 23, 1998
A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem cells in 318 patients with stage II-III breast cancerL S Schwartzberg, C H Weaver, R Birch, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 1998
Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantationK M Sullivan, E Kansu, B Storer, et al.Pageof 31